Literature DB >> 30327979

A literature review of perioperative antibiotic administration in surgery for medication-related osteonecrosis of the jaw.

Masaya Akashi1, Junya Kusumoto2, Daisuke Takeda3, Takashi Shigeta4, Takumi Hasegawa3, Takahide Komori3.   

Abstract

PURPOSE: Few studies exist that focus on the details of perioperative antibiotic administration for surgery to treat medication-related osteonecrosis of the jaw (MRONJ). The regime and duration of perioperative antibiotics applied in published studies were reviewed to clarify appropriate perioperative antibiotic use in MRONJ surgery.
METHODS: A literature search was conducted using the MEDLINE database via PubMed.
RESULTS: The search resulted in 453 hits on PubMed. After reading the downloaded full-text articles, 17 articles met the inclusion and exclusion criteria. The most common perioperative antibiotic used for MRONJ surgery was a combination of penicillin-based antibiotics and β-lactamase inhibitor (52.9%), and the second most common regime was penicillin-based antibiotics with metronidazole (17.6%). The duration of administration was 2 weeks postoperatively in nine studies, whereas four studies applied long-term administration (2-6 weeks postoperatively).
CONCLUSIONS: Oral and maxillofacial surgeons mostly prefer penicillin-based antibiotics plus β-lactamase inhibitor or metronidazole for MRONJ surgery. The duration of administration of these medications may be based on empirical experience.

Entities:  

Keywords:  Bacterial sampling; Duration; Medication-related osteonecrosis of the jaw; Perioperative antibiotic; Surgery

Mesh:

Substances:

Year:  2018        PMID: 30327979     DOI: 10.1007/s10006-018-0732-8

Source DB:  PubMed          Journal:  Oral Maxillofac Surg        ISSN: 1865-1550


  48 in total

1.  Antibiotic prophylaxis in clean-contaminated head and neck cases with microvascular free flap reconstruction: A systematic review and meta-analysis.

Authors:  Yarah M Haidar; Prem B Tripathi; Tjoson Tjoa; Sartaaj Walia; Lishi Zhang; Yanjun Chen; Danh V Nguyen; Hossein Mahboubi; William B Armstrong; Julie A Goddard
Journal:  Head Neck       Date:  2017-10-30       Impact factor: 3.147

2.  Long-term outcomes of surgical resection of the jaws in cancer patients with bisphosphonate-related osteonecrosis.

Authors:  Alberto Bedogni; Giorgia Saia; Giordana Bettini; Anita Tronchet; Andrea Totola; Giorgio Bedogni; Giuseppe Ferronato; Pier Francesco Nocini; Stella Blandamura
Journal:  Oral Oncol       Date:  2011-03-24       Impact factor: 5.337

3.  Relevant factors for treatment outcome and time to healing in medication-related osteonecrosis of the jaws - A retrospective cohort study.

Authors:  Ana Silva Martins; João André Correia; Francisco Salvado; Cecília Caldas; Nuno Santos; António Capelo; Paulo Palmela
Journal:  J Craniomaxillofac Surg       Date:  2017-07-28       Impact factor: 2.078

4.  Medication-related osteonecrosis of the jaw in oncological patients with skeletal metastases: conservative treatment is effective up to stage 2.

Authors:  R G Coropciuc; K Grisar; T Aerden; M Schol; J Schoenaers; C Politis
Journal:  Br J Oral Maxillofac Surg       Date:  2017-07-29       Impact factor: 1.651

Review 5.  Carbapenem resistance: overview of the problem and future perspectives.

Authors:  Georgios Meletis
Journal:  Ther Adv Infect Dis       Date:  2016-02

6.  Treatment of bisphosphonate-related osteonecrosis of the jaws: presentation of a protocol and an observational longitudinal study of an Italian series of cases.

Authors:  Sebastiano Ferlito; Sergio Puzzo; Filippo Palermo; Placido Verzì
Journal:  Br J Oral Maxillofac Surg       Date:  2011-09-09       Impact factor: 1.651

7.  The impact of surgical intervention and antibiotics on MRONJ stage II and III - Retrospective study.

Authors:  Matthias Zirk; Matthias Kreppel; Johannes Buller; Julij Pristup; Franziska Peters; Timo Dreiseidler; Max Zinser; Joachim E Zöller
Journal:  J Craniomaxillofac Surg       Date:  2017-06-04       Impact factor: 2.078

8.  Surgical management of bisphosphonate induced osteonecrosis of the jaws.

Authors:  R A Williamson
Journal:  Int J Oral Maxillofac Surg       Date:  2009-12-16       Impact factor: 2.789

9.  Disease Stage and Mode of Therapy Are Important Determinants of Treatment Outcomes for Medication-Related Osteonecrosis of the Jaw.

Authors:  Salvatore L Ruggiero; Nina Kohn
Journal:  J Oral Maxillofac Surg       Date:  2015-12       Impact factor: 1.895

10.  Oral microbiota and host innate immune response in bisphosphonate-related osteonecrosis of the jaw.

Authors:  Smruti Pushalkar; Xin Li; Zoya Kurago; Lalitha V Ramanathapuram; Satoko Matsumura; Kenneth E Fleisher; Robert Glickman; Wenbo Yan; Yihong Li; Deepak Saxena
Journal:  Int J Oral Sci       Date:  2014-08-08       Impact factor: 6.344

View more
  9 in total

1.  Evaluation of advanced platelet-rich fibrin (PRF) as a bio-carrier for ampicillin/sulbactam.

Authors:  Anton Straub; Andreas Vollmer; Thiên-Trí Lâm; Roman C Brands; Maximilian Stapf; Oliver Scherf-Clavel; Max Bittrich; Andreas Fuchs; Alexander C Kübler; Stefan Hartmann
Journal:  Clin Oral Investig       Date:  2022-08-09       Impact factor: 3.606

2.  Concentration of Penicillin G in Jawbone Affected by Antiresorptive Agent-Related Osteonecrosis Following a Single Preoperative Dose.

Authors:  Philipp Poxleitner; Michael Andreas Ermer; Rainer Trittler; Carolin Lena Feuerstein; Jörg-Elard Otten; Rainer Schmelzeisen; Pit Jacob Voss; David Steybe
Journal:  Antibiotics (Basel)       Date:  2020-12-27

3.  Treatment of Stage 2 Medication-Induced Osteonecrosis of the Jaw: A Case Series.

Authors:  Guillermo Pardo-Zamora; Yanet Martínez; Jose Antonio Moreno; Antonio J Ortiz-Ruíz
Journal:  Int J Environ Res Public Health       Date:  2021-01-24       Impact factor: 3.390

4.  Porphyromonas, Treponema, and Mogibacterium promote IL8/IFNγ/TNFα-based pro-inflammation in patients with medication-related osteonecrosis of the jaw.

Authors:  Qingxiang Li; Yinfei Pu; Han Lu; Ning Zhao; Yifei Wang; Yuxing Guo; Chuanbin Guo
Journal:  J Oral Microbiol       Date:  2020-11-23       Impact factor: 5.474

5.  Effectiveness of surgery and hyperbaric oxygen for antiresorptive agent-related osteonecrosis of the jaw: A subgroup analysis by disease stage.

Authors:  Takuma Watanabe; Keita Asai; Shizuko Fukuhara; Ryuji Uozumi; Kazuhisa Bessho
Journal:  PLoS One       Date:  2021-01-04       Impact factor: 3.240

Review 6.  An Overview of Clinical Oncology and Impact on Oral Health.

Authors:  Jack A Harris; Giulia Ottaviani; Nathaniel S Treister; Glenn J Hanna
Journal:  Front Oral Health       Date:  2022-04-25

Review 7.  Can intracellular Staphylococcus aureus in osteomyelitis be treated using current antibiotics? A systematic review and narrative synthesis.

Authors:  Anja R Zelmer; Renjy Nelson; Katharina Richter; Gerald J Atkins
Journal:  Bone Res       Date:  2022-08-12       Impact factor: 13.362

Review 8.  Medication-related Osteonecrosis of the Jaw: A Review.

Authors:  Nouf A AlDhalaan; Asma BaQais; Ahmad Al-Omar
Journal:  Cureus       Date:  2020-02-10

Review 9.  Schemes for Drug-Induced Treatment of Osteonecrosis of Jaws with Particular Emphasis on the Influence of Vitamin D on Therapeutic Effects.

Authors:  Filip Michalak; Sylwia Hnitecka; Marzena Dominiak; Kinga Grzech-Leśniak
Journal:  Pharmaceutics       Date:  2021-03-08       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.